Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report

BACKGROUND: The majority of patients diagnosed with hepatocellular carcinoma (HCC) have advanced diseases and many are not eligible for curative therapies. CASE PRESENTATION: We report a rare case of HCC from a patient who had a complete response (CR) with the use of combination of Lenvatinib and Pe...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Liu, Zhaonan, Li, Xingjie, He, Xuequn, Xu, Yingchun, Wang, Xi
Format: Artigo
Language:Inglês
Published: BioMed Central 2019
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839182/
https://ncbi.nlm.nih.gov/pubmed/31703571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6287-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items